Paper34858342
miRNA, lncRNA and circRNA: Targeted Molecules Full of Therapeutic Prospects in the Development of Diabetic Retinopathy.
Chang X and 7 others. Front Endocrinol (Lausanne), 2021. Cited by 51 papers, by iCite.
Cite this record
ConductScience Library. miRNA, lncRNA and circRNA: Targeted Molecules Full of Therapeutic Prospects in the Development of Diabetic Retinopathy. Papers, record 34858342. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34858342
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- miRNA, lncRNA and circRNA: Targeted Molecules Full of Therapeutic Prospects in the Development of Diabetic Retinopathy.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetic Retinopathy | Major topic |
| MicroRNAs | Major topic |
| RNA, Circular | Major topic |
| RNA, Long Noncoding | Major topic |
| Animals | |
| Gene Expression Regulation | |
| Humans |
Source PubMed
References119
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11134897 | Lipofuscin-formation in cultured retinal pigment epithelial cells is related to their melanin content. | Free Radic Biol Med | 2001 | https://conductscience.org/library/papers/11134897 | PubMed |
| 2 | 31408201 | MiR-203a-3p inhibits retinal angiogenesis and alleviates proliferative diabetic retinopathy in oxygen-induced retinopathy (OIR) rat model via targeting VEGFA and HIF-1α. | Clin Exp Pharmacol Physiol | 2020 | https://conductscience.org/library/papers/31408201 | PubMed |
| 3 | 31199706 | MiR-30a Regulates S100A12-induced Retinal Microglial Activation and Inflammation by Targeting NLRP3. | Curr Eye Res | 2019 | https://conductscience.org/library/papers/31199706 | PubMed |
| 4 | 30883703 | Retinal and circulating miRNA expression patterns in diabetic retinopathy: An in silico and in vivo approach. | Br J Pharmacol | 2019 | https://conductscience.org/library/papers/30883703 | PubMed |
| 5 | 30835506 | MicroRNA-183 inhibition exerts suppressive effects on diabetic retinopathy by inactivating BTG1-mediated PI3K/Akt/VEGF signaling pathway. | Am J Physiol Endocrinol Metab | 2019 | https://conductscience.org/library/papers/30835506 | PubMed |
| 6 | 32979189 | Bone marrow mesenchymal stem cells-induced exosomal microRNA-486-3p protects against diabetic retinopathy through TLR4/NF-κB axis repression. | J Endocrinol Invest | 2021 | https://conductscience.org/library/papers/32979189 | PubMed |
| 7 | 30936982 | miR-29a/b cluster suppresses high glucose-induced endothelial-mesenchymal transition in human retinal microvascular endothelial cells by targeting Notch2. | Exp Ther Med | 2019 | https://conductscience.org/library/papers/30936982 | PubMed |
| 8 | 33309614 | Circ-ITCH restrains the expression of MMP-2, MMP-9 and TNF-α in diabetic retinopathy by inhibiting miR-22. | Exp Mol Pathol | 2021 | https://conductscience.org/library/papers/33309614 | PubMed |
| 9 | 19571010 | Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. | Proc Natl Acad Sci U S A | 2009 | https://conductscience.org/library/papers/19571010 | PubMed |
| 10 | 32165827 | MicroRNA-29b-3p inhibits cell proliferation and angiogenesis by targeting VEGFA and PDGFB in retinal microvascular endothelial cells. | Mol Vis | 2020 | https://conductscience.org/library/papers/32165827 | PubMed |
| 11 | 33530902 | Decreased lncRNA SNHG16 Accelerates Oxidative Stress Induced Pathological Angiogenesis in Human Retinal Microvascular Endothelial Cells by Regulating miR-195/mfn2 Axis. | Curr Pharm Des | 2021 | https://conductscience.org/library/papers/33530902 | PubMed |
| 12 | 32467994 | LncRNA GAS5 suppresses ER stress‑induced apoptosis and inflammation by regulating SERCA2b in HG‑treated retinal epithelial cell. | Mol Med Rep | 2020 | https://conductscience.org/library/papers/32467994 | PubMed |
| 13 | 32660795 | MicroRNA-203a-3p regulates CoCl2-induced apoptosis in human retinal pigment epithelial cells by targeting suppressor of cytokine signaling 3. | J Diabetes Complications | 2020 | https://conductscience.org/library/papers/32660795 | PubMed |
| 14 | 30485520 | MicroRNA-9 inhibits retinal neovascularization in rats with diabetic retinopathy by targeting vascular endothelial growth factor A. | J Cell Biochem | 2019 | https://conductscience.org/library/papers/30485520 | PubMed |
| 15 | 31830266 | Glucose-induced microRNA-218 suppresses the proliferation and promotes the apoptosis of human retinal pigment epithelium cells by targeting RUNX2. | Biosci Rep | 2019 | https://conductscience.org/library/papers/31830266 | PubMed |
| 16 | 25827060 | Molecular mechanism of ER stress-induced gene expression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in macrophages. | FEBS J | 2015 | https://conductscience.org/library/papers/25827060 | PubMed |
| 17 | 26657629 | Circular RNAs are long-lived and display only minimal early alterations in response to a growth factor. | Nucleic Acids Res | 2016 | https://conductscience.org/library/papers/26657629 | PubMed |
| 18 | 32319024 | Inhibition of hsa_circ_0002570 suppresses high-glucose-induced angiogenesis and inflammation in retinal microvascular endothelial cells through miR-1243/angiomotin axis. | Cell Stress Chaperones | 2020 | https://conductscience.org/library/papers/32319024 | PubMed |
| 19 | 33291567 | Small-Molecule Modulation of PPARs for the Treatment of Prevalent Vascular Retinal Diseases. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/33291567 | PubMed |
| 20 | 29749515 | Significant role of microRNA‑219‑5p in diabetic retinopathy and its mechanism of action. | Mol Med Rep | 2018 | https://conductscience.org/library/papers/29749515 | PubMed |
Cited by34
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 51 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42985458 | Circulating and extracellular vesicle-associated non-coding RNAs in diabetic retinopathy: a stage-aware framework for network-informed biomarker panels. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42985458 | PubMed |
| 42622757 | Dysfunction of the Neurovascular Unit in Diabetic Retinopathy: Advances from Molecular Mechanisms to Targeted Interventions. | Stem Cell Rev Rep | 2026 | https://conductscience.org/library/papers/42622757 | PubMed |
| 42346183 | A Pilot Study of Circulating microRNA Expression in Newly Diagnosed Type 2 Diabetes Using a Pooled Sample Approach. | Clin Pract | 2026 | https://conductscience.org/library/papers/42346183 | PubMed |
| 41675859 | Nanocarrier-based CircRNA therapeutics in inherited retinal dystrophies. | Ann Med Surg (Lond) | 2026 | https://conductscience.org/library/papers/41675859 | PubMed |
| 41405560 | Circular RNAs as Biomarkers and Therapeutic Targets in Diabetic Cardiovascular Complications. | Endocrinol Diabetes Metab | 2026 | https://conductscience.org/library/papers/41405560 | PubMed |
| 41321575 | Regulatory roles of circular RNAs in poultry diseases: mechanisms and research advances. | Front Vet Sci | 2025 | https://conductscience.org/library/papers/41321575 | PubMed |
| 40965405 | LINC02099 Promotes Retinal Extracellular Matrix Deposition in Diabetic Mice Via the miRNA-214-3p/CTSS Axis. | Invest Ophthalmol Vis Sci | 2025 | https://conductscience.org/library/papers/40965405 | PubMed |
| 40593275 | LncRNA TDRG1 facilitates high glucose-induced retinal microvascular endothelial cell injury via miR-7-5p/G3BP2. | In Vitro Cell Dev Biol Anim | 2025 | https://conductscience.org/library/papers/40593275 | PubMed |
| 40275308 | SEM model analysis of diabetic patients' acceptance of artificial intelligence for diabetic retinopathy. | BMC Med Inform Decis Mak | 2025 | https://conductscience.org/library/papers/40275308 | PubMed |
| 40236860 | Curcumol ameliorates diabetic retinopathy via modulating fat mass and obesity-associated protein-demethylated MAF transcription factor G antisense RNA 1. | World J Diabetes | 2025 | https://conductscience.org/library/papers/40236860 | PubMed |
| 40164888 | The Role of Non-coding RNAs in Diabetic Retinopathy: Mechanistic Insights and Therapeutic Potential. | Mol Neurobiol | 2025 | https://conductscience.org/library/papers/40164888 | PubMed |
| 39773033 | Research Hotspots and Trends of RNA Research in Diabetic Retinopathy: Insights From Bibliometric Analysis. | Endocr Metab Immune Disord Drug Targets | 2025 | https://conductscience.org/library/papers/39773033 | PubMed |
| 39675825 | Advancement in predictive biomarkers for gestational diabetes mellitus diagnosis and related outcomes: a scoping review. | BMJ Open | 2024 | https://conductscience.org/library/papers/39675825 | PubMed |
| 39564450 | Potential Diagnostic Markers of Diabetic Retinopathy: Serum LncRNA MIAT, HOTTIP, SNHG16. | Diabetes Metab Syndr Obes | 2024 | https://conductscience.org/library/papers/39564450 | PubMed |
| 39135128 | Circular RNA NFIX Functions as an Oncogene in Non-Small Cell Lung Cancer by Modulating the miR-214-3p/TRIAP1 Axis. | Clin Respir J | 2024 | https://conductscience.org/library/papers/39135128 | PubMed |
| 38978623 | The m6A-ncRNAs axis in diabetes complications: novel mechanism and therapeutic potential. | Front Endocrinol (Lausanne) | 2024 | https://conductscience.org/library/papers/38978623 | PubMed |
| 38739522 | LncRNA XIST promotes neovascularization in diabetic retinopathy by regulating miR-101-3p/VEGFA. | Arch Endocrinol Metab | 2024 | https://conductscience.org/library/papers/38739522 | PubMed |
| 38396799 | Classical and Innovative Evidence for Therapeutic Strategies in Retinal Dysfunctions. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38396799 | PubMed |
| 38385027 | Ferroptosis-related exosomal non-coding RNAs: promising targets in pathogenesis and treatment of non-malignant diseases. | Front Cell Dev Biol | 2024 | https://conductscience.org/library/papers/38385027 | PubMed |
| 38356865 | Exosomal noncoding RNA: A potential therapy for retinal vascular diseases. | Mol Ther Nucleic Acids | 2024 | https://conductscience.org/library/papers/38356865 | PubMed |
Genes113
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34858342
GET https://conductscience.org/api/papers/v1/34858342/references?page=2